| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |